gbfi

Strong R&D

Reagena is committed to development, production and marketing of innovative diagnostics products.

Proven examples of these are the proprietary immuno-chromatography technology together with ReaScan reader and the point-of-care and the EIA tests for acute Hantavirus infections and immunity.

The easy-to-use rapid tests of Reagena enable excellent sensitivity and specificity, and combine the advantages of traditional laboratory tests and point-of-care testing for laboratory clinicians.

The most recent (2013) addition to the Reagena zoonosis portfolio was new, high performance test for diagnosing acute tickborne encephalitis (TBE).  

During the spring 2014, our zoonosis portfolio is being complemented with the world's first rapid test for tick-borne encephalitis virus - ReaScan TBE.

Reagena professionals work in close collaboration with leading international universities and research institutes in several countries.

Fotolia_39241220_.jpg